NASDAQ$ICUI
ICU Medical Inc. · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Announced fourth quarter 2021 results
ICU Medical reported Q4 2021 revenue of $340.5 million, compared to $320.5 million in the same period last year. GAAP net income for the fourth quarter of 2021 was $19.9 million, or $0.91 per diluted share, as compared to GAAP net income of $26.1 million, or $1.21 per diluted share, for the fourth quarter of 2020.
- Fourth quarter revenue was $340.5 million, compared to $320.5 million in the same period last year.
- GAAP gross profit for the fourth quarter of 2021 was $127.5 million, as compared to $119.9 million in the same period last year.
- GAAP net income for the fourth quarter of 2021 was $19.9 million, or $0.91 per diluted share, as compared to GAAP net income of $26.1 million, or $1.21 per diluted share, for the fourth quarter of 2020.
- Adjusted diluted earnings per share for the fourth quarter of 2021 was $1.82 as compared to $1.77 for the fourth quarter of 2020.
Headline financials
Revenue & EPS history
ICU Medical · Revenue · Quarterly
$341M
Revenue by segment
ICU Medical · $240M total across 2 segments · Q4 2021
- Consumables$148M+20.1%61.5%
- Infusion Systems$92.6M+0.9%38.5%
Forward guidance
For the Fiscal Year 2022, the Company expects adjusted EBITDA to be in the range of $450 million to $500 million, and adjusted diluted EPS to be in the range of $9.00 to $10.50.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+0.3%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.3%
Avg return
30 days after
52%
38 / 73 earnings
Positive
+22.4%
Q2 2024
Best reaction
-33.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.8% | -0.8% | +10.7% | |
| Q4 2025 | +4.8% | +3.6% | -16.3% | |
| Q3 2025 | +8.2% | +7.3% | +9.9% | |
| Q1 2025 | -3.3% | -4.9% | -6.9% | |
| Q4 2024 | -2.3% | -4.1% | -6.4% | |
| Q3 2024 | -1.9% | -5.8% | -7.1% | |
| Q2 2024 | +22.4% | +19.7% | +31.2% | |
| Q1 2024 | -0.1% | +6.3% | +7.6% | |
| Q4 2023 | +6.5% | -0.2% | +1.6% | |
| Q3 2023 | -17.8% | -20.2% | -15.9% | |
| Q2 2023 | -15.2% | -15.6% | -16.8% | |
| Q1 2023 | +13.3% | +8.7% | +3.9% | |
| Q4 2022 | -3.6% | -4.2% | -7.3% | |
| Q3 2022 | +6.7% | +21.4% | +11.8% | |
| Q2 2022 | -7.4% | -4.7% | -8.0% | |
| Q1 2022 | -10.4% | -15.0% | -14.9% | |
| Q4 2021 | +5.8% | +9.0% | +4.3% | |
| Q3 2021 | +2.1% | +2.7% | -6.4% | |
| Q2 2021 | +0.7% | +1.2% | +6.1% | |
| Q1 2021 | -5.0% | -6.5% | -2.1% | |
| Q4 2020 | -5.5% | -6.8% | -4.4% | |
| Q3 2020 | +0.6% | +4.8% | +5.6% | |
| Q2 2020 | +8.8% | +5.0% | +9.8% | |
| Q1 2020 | -8.8% | -13.7% | -8.0% | |
| Q4 2019 | -4.2% | -4.8% | -8.2% | |
| Q3 2019 | +6.9% | +4.3% | +6.8% | |
| Q2 2019 | -33.3% | -31.2% | -36.6% | |
| Q1 2019 | -2.7% | -3.3% | -2.2% | |
| Q4 2018 | +2.5% | -4.9% | -2.8% | |
| Q3 2018 | -10.6% | -14.8% | -10.6% | |
| Q2 2018 | +2.2% | +2.4% | +3.7% | |
| Q1 2018 | +1.4% | +4.3% | +12.4% | |
| Q4 2017 | +4.6% | +7.5% | +9.1% | |
| Q3 2017 | +8.6% | +10.1% | +11.7% | |
| Q2 2017 | -2.9% | -2.4% | +3.4% | |
| Q1 2017 | -0.2% | -0.1% | +6.2% | |
| Q4 2016 | +0.7% | -1.0% | +1.5% | |
| Q3 2016 | -0.4% | -0.9% | +2.5% | |
| Q2 2016 | +7.5% | +6.1% | +8.6% | |
| Q1 2016 | -1.0% | — | — | |
| Q4 2015 | -8.7% | — | — | |
| Q3 2015 | +5.8% | — | — | |
| Q2 2015 | +19.9% | — | — | |
| Q1 2015 | +7.3% | — | — | |
| Q4 2014 | +2.2% | — | — | |
| Q3 2014 | +13.6% | — | — | |
| Q2 2014 | +10.5% | — | — | |
| Q1 2014 | +3.3% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | +3.0% | — | — | |
| Q2 2013 | -6.7% | — | — | |
| Q1 2013 | +1.3% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | -0.2% | — | — | |
| Q1 2012 | +0.8% | — | — | |
| Q4 2011 | +1.9% | — | — | |
| Q3 2011 | +0.2% | — | — | |
| Q2 2011 | -3.9% | — | — | |
| Q1 2011 | +2.2% | — | — | |
| Q4 2010 | +0.1% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +3.4% | — | — | |
| Q1 2010 | -1.0% | — | — | |
| Q4 2007 | -1.0% | — | — | |
| Q4 2009 | -1.0% | — | — | |
| Q3 2009 | -0.8% | — | — | |
| Q3 2008 | -0.8% | — | — | |
| Q2 2009 | -0.6% | — | — | |
| Q2 2008 | -3.9% | — | — | |
| Q1 2009 | -3.9% | — | — | |
| Q4 2008 | -3.9% | — | — | |
| Q1 2008 | -3.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro